Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for Symptomatic Remission in Schizophrenia
NCT01577186Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of paliperidone in schizophrenia, sponsored by Johnson & Johnson. Started Jul 2008; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01577186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577186.